Cellivery Therapeutics, Inc. 268600.KQ Stock
6680 KRW
{{ price }}
0.000000%
{{change_pct}}%
COUNTRY
South Korea
Exchange
KOSDAQ
Market Cap
52.24B KRW
LOW - HIGH [24H]
6680
-
6680 KRW
VOLUME [24H]
0 KRW
{{ volume }}
P/E Ratio
0
Earnings per share
0 KRW
Cellivery Therapeutics, Inc. Price Chart
Cellivery Therapeutics, Inc. 268600.KQ Financial and Trading Overview
| Cellivery Therapeutics, Inc. stock price | 6680 KRW |
| Previous Close | 6680 KRW |
| Open | 0 KRW |
| Bid | 0 KRW x 0 |
| Ask | 0 KRW x 0 |
| Day's Range | 6680 - 6680 KRW |
| 52 Week Range | 6680 - 20900 KRW |
| Volume | 0 KRW |
| Avg. Volume | 1.15M KRW |
| Market Cap | 52.24B KRW |
| Beta (5Y Monthly) | 0.575573 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 KRW |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
268600.KQ Valuation Measures
| Enterprise Value | 488.94B KRW |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.4553244 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 22.981 |
| Enterprise Value/EBITDA | -10.415 |
Trading Information
Cellivery Therapeutics, Inc. Stock Price History
| Beta (5Y Monthly) | 0.575573 |
| 52-Week Change | -60.00000000000000000000000000000000% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 20900 KRW |
| 52 Week Low | 6680 KRW |
| 50-Day Moving Average | 11492.6 KRW |
| 200-Day Moving Average | 12832.53 KRW |
268600.KQ Share Statistics
| Avg. Volume (3 month) | 1.15M KRW |
| Avg. Daily Volume (10-Days) | 1.18M KRW |
| Shares Outstanding | 7.82M |
| Float | 29.87M |
| Short Ratio | N/A |
| % Held by Insiders | 17.12% |
| % Held by Institutions | 6.50% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | September 30, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | -256.47% |
| Operating Margin (ttm) | -240.93% |
| Gross Margin | 9.34% |
| EBITDA Margin | -220.65% |
Management Effectiveness
| Return on Assets (ttm) | -38.56% |
| Return on Equity (ttm) | -152.40% |
Income Statement
| Revenue (ttm) | 21.28B KRW |
| Revenue Per Share (ttm) | 855.4 KRW |
| Quarterly Revenue Growth (yoy) | 9999.29% |
| Gross Profit (ttm) | 24.15M KRW |
| EBITDA | -46945357824 KRW |
| Net Income Avi to Common (ttm) | -54566600704 KRW |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 32.53B KRW |
| Total Cash Per Share (mrq) | 935.45 KRW |
| Total Debt (mrq) | 66.94B KRW |
| Total Debt/Equity (mrq) | 210.95 KRW |
| Current Ratio (mrq) | 1.687 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | -51455672320 KRW |
| Levered Free Cash Flow (ttm) | -58287673344 KRW |
Profile of Cellivery Therapeutics, Inc.
| Country | South Korea |
| State | N/A |
| City | Seoul |
| Address | K·BIZ DMC Tower |
| ZIP | 121-904 |
| Phone | 82 2 6495 7866 |
| Website | https://www.cellivery.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 100 |
Cellivery Therapeutics, Inc. researches and develops therapeutic drugs for life-threatening diseases comprising cancer, inflammation, metabolic, and neurodegenerative diseases. It develops small molecule, antibody, and vaccine drugs based on its therapeutic molecule systemic delivery technology. The company was incorporated in 2014 and is based in Seoul, South Korea.
Q&A For Cellivery Therapeutics, Inc. Stock
What is a current 268600.KQ stock price?
Cellivery Therapeutics, Inc. 268600.KQ stock price today per share is 6680 KRW.
How to purchase Cellivery Therapeutics, Inc. stock?
You can buy 268600.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Cellivery Therapeutics, Inc.?
The stock symbol or ticker of Cellivery Therapeutics, Inc. is 268600.KQ.
How many shares does Cellivery Therapeutics, Inc. have in circulation?
The max supply of Cellivery Therapeutics, Inc. shares is 7.82M.
What is Cellivery Therapeutics, Inc. Price to Earnings Ratio (PE Ratio)?
Cellivery Therapeutics, Inc. PE Ratio is now.
What was Cellivery Therapeutics, Inc. earnings per share over the trailing 12 months (TTM)?
Cellivery Therapeutics, Inc. EPS is 0 KRW over the trailing 12 months.